EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Recurrent hypoglycemia induced by clopidogrel: A case report and mini review

Weiguan Du iD, Haining Wang, Ye Liu, Tianpei Hong iD

Journal of Diabetes Investigation · 2024-03 · 15 (3) · 275-281

DOI: 10.1111/jdi.14110 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 08.12.2023. Verfasst von Weiguan Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Hypoglycemia, Hyperinsulinism, Autoimmune Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This report describes a patient who developed recurrent hypoglycemia episodes after 23 days of antiplatelet therapy with clopidogrel for left subclavian artery stent implantation. The patient suffered from palpitation, profuse sweating and weakness on the 23rd day of clopidogrel treatment. The minimum plasma glucose was 2.2 mmol/L, and the hypoglycemia was associated with significantly elevated levels of insulin. A diagnosis of insulin autoimmune syndrome (IAS) was made with the presence of insulin autoantibody and a comprehensive differential diagnosis of other conditions related with hypoglycemia. Clopidogrel was stopped, and the patient was treated with acarbose and had frequent low‐carbohydrate meals; his hypoglycemia did not occur within 10 days. To date, seven cases of IAS induced by clopidogrel have been reported. Most reported cases were male aged in their 70s, and the hypoglycemic attack appeared 1–4 weeks after exposure to clopidogrel, characterized by severe hyperinsulinemia hypoglycemia with high titers of insulin autoantibodies. Most IAS cases can resolve spontaneously when they stop using the trigger medicine. Severe cases had been treated with drugs that reduce pancreatic insulin secretion (such as somatostatin and diazoxide), immunosuppressants (glucocorticoids, azathioprine and rituximab) and even immunoadsorption to remove the insulin autoantibody from the body. Considering the hypoglycemic attack might increase the risk of cardiovascular events among patients taking clopidogrel, we recommend that doctors should be aware of IAS as a rare severe adverse effect of clopidogrel, and be vigilant for the symptoms related with hypoglycemia in clopidogrel users.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoglycemiaHyperinsulinismAutoimmune DiseasesHumansMaleFemaleClopidogrelHypoglycemic AgentsInsulinAutoantibodies

Stichwörter der Autor:innen

ClopidogrelHypoglycemiaInsulin autoimmune syndrome

Substanzen

ClopidogrelHypoglycemic AgentsInsulinAutoantibodies

Autor:innen und Institutionen

  • Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Weiguan Du, Tianpei Hong

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Du, W., Wang, H., Liu, Y., & Hong, T. (2024). Recurrent hypoglycemia induced by clopidogrel: A case report and mini review. Journal of Diabetes Investigation, 15(3), 275-281. https://doi.org/10.1111/jdi.14110

Vancouver

Du W, Wang H, Liu Y, Hong T. Recurrent hypoglycemia induced by clopidogrel: A case report and mini review. Journal of Diabetes Investigation. 2024;15(3):275-281. doi:10.1111/jdi.14110

BibTeX
@article{Du2024,
  author = {Du, Weiguan and Wang, Haining and Liu, Ye and Hong, Tianpei},
  title = {Recurrent hypoglycemia induced by clopidogrel: A case report and mini review},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  volume = {15},
  number = {3},
  pages = {275--281},
  doi = {10.1111/jdi.14110}
}
Kostenlos starten →